BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials

Liu, K; Huang, Y; Xu, Y; Wang, GQ; Cai, SL; Zhang, X; Shi, TP

Zhang, X; Shi, TP (通讯作者)，Third Med Ctr, Dept Urol, PLA Gen Hosp, Yongding Rd 69, Beijing 100039, Peoples R China.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023; 72 (8): 2557

Abstract

BackgroundIn patients with advanced clear cell renal cell carcinoma, despite the undoubted benefits from immune checkpoint inhibitor (ICI)-based thera......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索